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           Symptomatic aortic stenosis (AS) is an increasing phenomenon as more adults live 
longer. The gold standard for treating AS is surgical aortic valve replacement (SAVR). 
Frequently, as older individuals with AS often have multiple comorbidities, a SAVR is 
determined to be too high risk. Therefore, a less invasive treatment option is available, 
namely a transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve 
replacement (TAVR). Such biomedical procedures have encouraged life extension and 
the decision to intervene commonplace with the aging population. Without an 
intervention, significant debilitating symptoms affect a person’s quality of life (QoL). 
Multiple quantitative studies evaluating QoL before and after a TAVI have been 
performed. However QoL has multiple attributes and is not a single construct. By 
limiting practice to these defined QoL measures, we exclude the human experience and 
what values individuals describe as important to them. The dilemma in the present 
medical model is influenced by two paradigms, evidence based medicine and patient 
centered medicine. 
            Some people opt not to have a TAVI. This study aims to understand what it is like 
living with aortic stenosis as perceived by the participant and to gain a more meaningful 
understanding of why some individuals with AS choose not to have this procedure 
performed. Using a convenience sample of patients who declined a TAVI, a telephone 
interview with the person focused on their perceived QoL and the implications 
determining not to pursue a TAVI. In this qualitative phenomenological design, open-
ended questions included: 1) What is it like to live with Aortic Stenosis. 2) Why did you 
choose not to have the TAVI? Interviews will explore emerging themes.  Advanced 
practice nurses are in ideal positions for performing research to gain greater insight on the 
complexity of people’s health choices. As the incidence of AS occurs more frequently in 
the increasing aged population, TAVI offers a treatment option for those patients who are 
symptomatic with AS and are not surgical candidates. However, health care providers 
should focus on the illness, not the disease, and explore the patients’ biopsychosocial 
values with their medical needs.  The information gathered in this study will help guide 
heath care providers with offering holistic health care incorporating both paradigms of 
evidence based practice and patient centered medicine options on treatment for people 
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           Aortic stenosis (AS) is the most common valve disease in the United States (U.S.) 
(Nugteren & Sandau, 2010) affecting 2.8% of adults over the age of 75 (Go et al., 2013). 
According to the U.S. Census Bureau (2014) there will be 47.8 million people older than 
65 projected in 2015. This cohort will rise to 88.5 million by 2050 and an estimated 3.5 
million people will be living with AS by 2020 (Horrocks, Closs, & Astin, 2013). The 
population of aging adults is increasing due to better health initiatives, and medical 
interventions parallel the increase incidence of AS in the growing aged population. 
           Aortic stenosis is the narrowing of the aortic tricuspid valve orifice producing 
constricted outflow from the left ventricle causing left ventricular hypertrophy. This 
compensatory hypertrophy contributes to debilitating symptoms including exertional 
dyspnea, angina, syncope, orthopnea, paroxysmal nocturnal dyspnea, fatigue, and 
exercise intolerance, many of which affect people’s quality of life (QoL) (Charlson, 
Legedza & Hamel, 2006). 
          Although surgical aortic valve replacement (SAVR) is optimal, there are inherent 
risks with cardiopulmonary bypass and aortic cross clamping. This operative risk along 
with patients who have significant comorbidities is not appropriate for one-third of 
patients with AS (Iung et al., 2005; McRae & Rodger, 2012). 
         The transcatheter aortic valve implantation (TAVI) is offered as a safe and viable 
treatment option for symptomatic AS patients. The procedure entails an insertable valve 
placed using a percutaneous approach. The U.S. Food and Drug Administration gave 
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commercial approval of the TAVI for treatment of severe symptomatic and inoperable 
status in 2011 and high risk but operable status in 2012 (Mack et al., 2013).  
           The decision to undergo the TAVI procedure is complex. Along with mortality 
and hemodynamic valve performance, determinants addressed in the preliminary work up 
are functional health status including evaluation of quality of life (QoL). Multiple 
quantitative research studies have been performed investigating QoL before and after 
TAVI that show improvement in individuals’ QoL as compared to standard medical 
therapy for non-surgical candidates (Bleiziffer et al., 2012; Krane et al., 2012; Reynolds 
et al., 2012; Shim, Russ, & Kaufman, 2006). Quality of life is not, however, a single 
construct but a blend of many variables (Ferrans et al., 2005). Many definitions describe 
functional abilities, sense of well-being, perceived physical capacity, satisfactory 
socioeconomic status, yet exclude the lived human experience or personal ethos in 
relation to their goals, expectations and concerns (Milton, 2013).                 
           Quality of life measures have multiple dynamic attributes, definitions, labels, and 
categories, yet by limiting practice to these defined QoL measures we exclude human 
experience and the values individuals describe as important to them. Quality of life 
instruments are generally quantitative in design (Milton, 2013; Ward-Smith, 2011). 
Quantitative measurements poorly evaluate beliefs or values that patients may ascribe to 
QoL. The World Health Organization identifies quality of life as embedded in one’s 
cultural, social, and environmental perspective of the individual’s perception of their life 
in relation to personal goals, expectations, standards and concerns (WHO, 2012).  
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          The decision to have a TAVI is presently influenced by two paradigms in the 
medical care model, evidence-based medicine and patient-centered medicine. The 
evidence-based medicine concept, introduced into scientific literature in the 1990s, 
gained popularity as clinical expertise and scientific research offered evidence toward 
high quality treatment. This positivistic, biomedical perspective (Bensing, 2000) directs 
the clinician focus toward treatment options with little influence of the patients’ 
uniqueness and preferences in the clinical decision making process. According to Shim, 
Russ & Kaufman (2006) medical practice defines clinical ethics rather than ethical-
decision-shaping practice. The resurgence of patient-centered medicine involves the 
biopsychosocial paradigm with focus on including a patient’s participation in clinical 
decision-making. However, empirical evidence for this practice is limited because the 
underlying concept is multi-dimensional and therefore difficult to test.  
        Although research supports the use of the TAVI procedure to reduce mortality and 
morbidity (Holmes et al., 2012; Reynolds et al., 2012, & Thourani et al., 2013) the focus 
of most research is based on an assumption that greater quantity of life is the ultimate 
patient goal rather than acceptance of a reduction in life expectancy with the goal of 
determining the direction of remaining life. With more frequency, many people are 
offered medical interventions aimed at prolonging life. The increase in life-prolonging 
intervention suggests that such biomedical possibilities are germane for elderly 
individuals (Shim, Russ & Kaufman, 2006). Yet, there is an ethical dilemma between the 
pursuit of biomedical interventions and the discussion of ultimate personal goals. By not 
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substantiating the personal goals of an individual, we ignore the patient’s approach to 
aging and dying.   
Greater pursuit of medical interventions necessitates understanding that each 
person is inherently different when choosing personal health in finding meaning related 
to their quality of life. Making health care choices is not a numerical or objective 
equation determined by an algorithm, rather a myriad of unique values to which an 
individual ascribes. Only individuals can rate their personal QoL because “quality” is 
highly subjective representing individual values that are inclusive of physical health, 
psychological health, level of independence, social relationships, environment, and 
spiritual and personal beliefs.  The choice of quantity of life as a goal is an option, but 
information limited to quantity is often insufficient for people to make an informed 
treatment decision. Although the TAVI procedure is a novel option for patients with 
symptomatic AS, the decision-making process should include relief of aortic stenosis 
related symptoms as well as an individual’s values that determine their quality of life.  
Because of prolonged life expectancy, health care providers will see more people 
with symptomatic AS. A model of ethical practice should be the blend of evidence-based 
medicine and patient-centered medicine. By understanding the patients’ values we can 
integrate the biomedical and social science paradigms. An approach to identification of 
treatment options is valuing the patient’s personal goals with informed decisions by the 
patient. 
As nursing is one of the most trusted professions (Milton, 2013), we have the 
opportunity to influence QoL research with the focus on holistic well-being. According to 
 5 
 
the International Council of Nurses (2012) inherent nursing values include respecting 
human rights, the right to life and to be treated with respect, as well as others. The 
American Nurse Association Code of Ethics for Nurses with Interpretive Statements 
(2015) identifies respect for human dignity and the right to self-determination therefore 
illuminating ethical principles that direct the profession of nursing.  
Why is the problem worth exploring?  
Making health care decisions is a complex process (Barclay, Momen, Case-
Upton, Kuhn, & Smith, 2011; Milton, 2013).  Providers need to include and honor a 
person’s experience and self-perceived QoL when making subsequent choices in health 
care decisions. The selection of people used in this study is optimal because of the 
inherent poor prognosis and rapid disease progression of AS. According to Holmes et al. 
(2012) a patient’s decision for treatment of AS ultimately should be a shared decision 
among the informed patient, family and provider. The goal for optimal health care 
decisions should include medically reasonable options for treatment that match a 
patient’s values, goals, and preferences (Allen et al., 2012). Health care providers should 
focus on the illness, not the disease, and explore patients’ biopsychosocial values in 
concert with their medical needs. Only when we incorporated the patient’s wishes, can 
we provide holistic quality care (Gardiner, Wilson, Ingleton, & Gott, 2013; Milton, 
2013). 
Relationship to Advanced Practice Nursing  
Because of increasing life expectancy, advanced practice nurses will be seeing 
more people with symptomatic AS seeking information about the disease process and 
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treatment options. As advanced nurse practitioners represent approximately eight percent 
(Naylor & Kurtzman, 2010) of the nursing workforce, there are profound implications for 
practice in the chronically ill and elderly populations. The American Academy of Nurse 
Practitioners (AANP) (2015) practice model’s priority is placed on patient and family 
education and facilitating patients participation in self-care.  
Based on nurse practitioner’s education and expertise, nurse practitioners should 
be on the forefront of evolving health care. This has profound implications for APN 
practice as nurses are in a position to provide education, guidance, and treatment options 
for the promotion of health and therapeutic modalities for patients along the AS disease 
process.  
Theoretical Framework 
Sister Callista Roy’s Adaptive Model posits that understanding the impact of 
chronic illness and well-being integrates the biological, social, and psychological 
complexities of older people's lives. Roy’s Adaptive Model fosters variation for 
individuals’ psychological needs, concept of self, roles and inter-dependence with others, 
which contributes to health, quality of life, as well as dying with dignity. By assessing 
factors that influence adaptive abilities, one can enhance the ultimate goal of achieving 
dignity and integrity. 
            Using an interactive process of Roy’s theoretical framework, ethical enquiry, 
combined with Heidegger’s phenomenology allows the researcher to identify emerging 
themes. The ontological view that multidimensional realities exist which are influenced 
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by many internal and external forces, offers integrity and meaning to the patient’s choice 
to have a TAVI procedure or to choose a more palliative option.  
Roy’s Adaptive Model provided the theoretical framework for this study because 
the focus is on identifying factors that affect the quality of life of elderly AS patients and 
her understanding that health and illness are inevitable dimensions of the person’s life. 
These findings provide an initial direction for further theory enhancement and suggest 
that there should be a focus on the development of nursing research that include physical 

















Review of Literature 
The diagnosis of AS is increasing in the U.S. population due in part to the aging 
of the population. The urgency of studying older adults’ treatment decisions is predicated 
upon a concern about the ethical practice implication of two main streams of health 
practice, one based on preservation of life, the other on the personal preferences of 
patients. The organization of this review is the prevalence, pathology, treatment 
modalities and inherent risks of treatment, TAVI determinants of QoL, and the ethical 
dilemma created when using present tools to assess QoL in aortic stenosis. A search of 
literature yielded eleven studies that were directly relevant to diagnosis, treatment and 
management for TAVI procedure, five studies pertinent to management of patients with 
valve disease, eight studies addressing QoL indicators in patient with valvular disease, 
and six recent discussions of the ethical imperatives of treatment verses no treatment, six 
studies germane to decision making and end of life discussions, and two related to 
phenomenological study. The time frame incorporated 2005 to 2015. 
Prevalence 
The prevalence of Aortic Stenosis has been widely identified. Nugteren and 
Sandau (2010) note AS is the most common disease in Europe and in the United States. 
Annually the American Heart Association (AHA), the Centers for Disease Control and 
Prevention (CDC), and the National Institutes of Health (NIH) gather the most up-to-date 
statistics on heart disease, stroke, other vascular diseases, which is reported in the Heart 
Disease and Stroke Statistical Update (Go, et al., 2013). The 2014 Update notes the 
prevalence of moderate or severe aortic stenosis in patients ≥75 years old is 2 .8% (95% 
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CI, 2 .1%–3 .7%) of the US population. These staggering numbers will be increasing with 
the increase of life expectancy. According to the American Heart Association 2014 
statistics, 1.5 million people in the United States (US) suffer from symptomatic AS, 
without surgical or procedural intervention, half of those patients will die within two to 
three years following the onset of symptoms (Bach, 2011; Nugteren & Sandau, 2010) and 
prognosis with medical management alone is poor (Go et al. 2014; Held, 2012; 
Nishimura et al., 2014; Webb et al., 2012). These implications are important for two 
reasons. Providers will see more patients with AS and patients who choose not to be 
treated, will have a shorter life span. Understanding and awareness of age related 
changes, such as increased risk for comorbidities and decrease in homeostasis capacity, is 
an essential part for elderly in determining treatment modalities. 
Pathology 
Causes of AS have been extensively described in literature. Eighty percent is due 
to natural progressive valvular calcification of the tricuspid aortic valve of the aging 
person (Rayner, Coffey, Newton, & Prendergast, 2014), other etiologies are congenital 
valvular abnormalities and rheumatic fever. Degenerative aortic valve stenosis (AVS) 
rarely becomes symptomatic before age 70, an age where comorbidities are often a 
combined factor. The progressive debilitating symptoms impact one’s QoL and 
contributes to people seeking treatment options for AS (Panos & George, 2004). 
Treatment/Associated Risk 
Surgical aortic valve replacement (SAVR) is the gold standard treatment for 
symptomatic AS (At-Attatr et al., 2009; Bleisiffer et al., 2012; Walther, Kenmfert, & 
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Mohr, 2012). Unfortunately, due to the high morbidity and mortality associated with 
surgical AVR and the increased risk of comorbidity in patients who have AS, some are 
deemed extremely high-risk surgical candidates therefore the condition may be 
considered inoperable (Held, 2012; Webb et al., 2007; Zierer, Wimmer-Greinecker, 
Martins, Moritz, & Doss, 2008). For inoperable patients with severe AS and significant 
comorbidities, the TAVI procedure is a less invasive and risk alternative (Al-Attar et al., 
2009; Cohn & Narayanasamy, 2007; Walther, Kempfert, & Mohr, 2012). A Transcatheter 
Aortic Valve Implantation (TAVI) is the replacement of an aortic valve using an 
endovascular approach via transfemoral, transapical, transaortic, or transcarotid access. 
The TAVI alternative procedure to open heart surgery for those with severe symptomatic 
AS has become a standard therapy for high-risk elderly patients (Walther et al., 2012). 
Since the first TAVI implantation in 2002, multiple studies have been conducted to 
examine improved survival of elderly patients with severe AS. The Placement of Aortic 
Transcatheter Valves (PARTNER) Trial, a large multicenter randomized control study, 
evaluated the TAVI versus AVS and the TAVI versus medicine treatments. The 
PARTNER A Trials’ data determined the two-year mortality of those who had a TAVI 
procedure was 33.9% as compared to patients who has a surgical AVR at 35%. The 
PARTNER B cohort was basing the two-year mortality on TAVI verses medical therapy, 
was respectively 43.3% and 68%. (Go et al., 2014). These research conclusions, while 
statistically significant for morbidity and mortality from the biomedical medical 




            As with any procedure there are some risk factors inherent with TAVI including, 
myocardial infarction, cerebral vascular events, acute renal insufficiency, major vascular 
injury, bleeding, emergent SAVR, paravalvular aortic regurgitation, acute renal injury, 
new onset atrial fibrillation, the need for a pacemaker or implantable cardioverter-
defibrillator, and death (Al-Attar et al., 2009; Charlson, 2006; Mack et al., 2013). In a 
study by Tamburino et al. (2011), mortality results from 663 consecutive post-TAVI 
patients in 2007 through 2009 were 15% at one year after procedure. These risk factors 
presented to potential candidates for the procedure may contribute to individuals’ 
decisions to forego a TAVI. This predicates the question of why there is a need to know 
how people come to a decision about refusing TAVI.  
Quality of Life Assessment 
Concurrently there is a growing body of literature validating improvement in QoL 
following a TAVI. The current research measures physical functioning, symptoms, self-
efficacy, role limitation, bodily pain, general health, vitality, social functioning, and 
mental well-being. The PARTNER Trial used the Kansas City Cardiomyopathy 
Questionnaire (KCCQ) and the 12-item Short Form-12 General Health Survey (SF-12) to 
assess the patient’s perspective of their health status (Bloomer, 2011). Other quantitative 
tools used are, European System for Cardiac Operative Risk Evaluation (EuroSCORE) 
(Marion & Rodger, 2012; Reynolds et al., 2012), EuroQOL group EQ (Reynolds et al., 
2012), Health Related Quality of Life (HRQOL) (Nugteren & Sandau, 2010), and 
Medical Outcome Trust Short Form 36-Item Health Survey (Krane et al., 2012; 
Bekeredjian et al., 2010). One year following TAVI, Bekeredjian et al. (2010) noted a 
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“significant improvement” in QoL health components, Reynolds et al. (2012) provided 
numerical improvements in all three of their QoL assessment tools, and Krane et al. 
(2012) results determined a significant QoL improvement.  
Ethical Dilemma 
These findings must be interpreted with caution however, by virtue of using 
quantitative measures typical of the study design. An interesting point noted by Milton 
(2013) is in using such tools to define QoL doesn’t incorporate the individual’s lived 
experience and lacks identifying that each person’s qualities are inherently different. 
Milton (2013) believes that making healthcare choices should not be a numerical, 
objective evaluation determined by an algorithm. Although health is the “absence of 
disease” from the biomedical perspective, the WHO (1946) recognized health as “ a state 
of complete physical, mental, and social well-being, not merely the absence of disease or 
infirmity”. Quality of Life needs to reflect the multidimensional construct of people as it 
has profound implications for health care practices.  
There is a shift in the understanding of what constitutes quality health care. Health 
care decisions require integration of research evidence and individual preferences. 
According to Bensing (2000) there is an ethical dilemma between the pursuit of 
biomedical possibilities, in other words evidence-based medicine, and the humanistic 
biopsychosocial perspective of patient-centered medicine. The enhancement of clinical 
expertise and scientific evidence offers highly technological treatment options yet 
medicine is founded upon the assumption that what needs to be known can be empirically 
shown and attributed to pathology. Yet nursing is defined by its emphasis on human 
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responses to illness or disease. An inherent value of nursing for human rights includes 
qualities of respect, compassion, and genuineness. Snellmand and Gedda (2012) note two 
ethical principles define nursing, the principle of human value and the right to experience 
a meaningful life. The International Council of Nurses (ICN) Code of Ethics (2012) 
emphasizes the nurse’s role to give information to support informed consent as well as 
the philosophy of nursing is to respect human rights and dignity. The IOM asserts that to 
provide high quality of care, it should be patient-centered. It is imperative that quality of 
care should include both clinical and experiential aspects of care as viewed from the 
patient’s perspective of their illness and its impact on his or her life.  
The diversity of patients’ unique experiences, needs, and preferences are 
overshadowed in clinical decision-making. The paradox of evidence-based medicine, as 
noted by Bensing (2000), is important as it offers high quality of care yet it lacks the 
uniqueness of each patient included in patient-centered medicine. Decisions on health 
care should be individualized as individuals may view choices between options and 
outcomes differently. Shim, Russ, & Kaufman (2006) examines the recent shift in how 
health care providers think about treatments, how older individuals conceive of 
themselves and their own aging, and how as a society the pursuit of medical treatment to 
maximize late life. An interesting point in their article delves into the pursuit of 
biomedical interventions to prolong life is altering the way we look at ageing and death.  
Although TAVI is an innovative technological procedure for high-risk surgical 
patients, not all patients want to undergo this procedure. There have been a large number 
of qualitative research studies conducted to measure mortality, morbidity and QoL. 
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However, very few include subjective data examining people’s reasons for choosing not 
to have the TAVI. Go et al. (2014) identified 50% of patients with severe aortic stenosis 
see a cardiothoracic surgeon and approximately 40% undergo AVR, the reasons for not 
undergoing AVR included high perioperative risk, age, lack of symptoms, and 
patient/family refusal. Bach, 2011, cites reasons for not undergoing AVR were 
comorbidities or high operative risk, advanced age or limited life expectancy, 
asymptomatic status, and patient or family refusal. Neither of these articles elaborated on 
the “patient and family refusal”. In this literature search, the researcher was unable to find 
articles that addressed reasons for not pursuing a TAVI. 
Previous research tools, predominantly a self-administered questionnaire to 
determine one’s QoL, have limitations as noted in this study. While there is a significant 
amount of quantitative research done on QoL measures, this study will focus on a 
qualitative approach to obtain a better understanding of what it is like living with 
symptomatic aortic stenosis and what themes evolve with those who decline to proceed 
with the procedure. There is a gap in literature of elderly people with multiple 
comorbidities comparing procedural treatment versus conservative management. A 
research of elderly people with comorbidities in chronic kidney disease, cancer and 
congestive heart failure found few similarities but many variables differ dramatically 
from AS patients. A recent article in the Journal of Clinical Nursing by Harwood & Clark 
(2014) summarizes that elderly chronic kidney disease patients’ decisions are influenced 
by health status, gender, knowledge, values, beliefs, past experiences, and preferences. 
Although the determinants are similar, the time frame from cessation of dialysis to death 
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is six to eight days (Fissell et al., 2005). As noted previously, from the first symptoms of 
AS to death is approximately two years. Another cohort that is similar regarding 
declining treatment is a patient with cancer. Radley and Payne (2009) report that decision 
making for cancer patients is individualistic and should be supported by accepting 
alternative values on how the meaning of life is addressed. Again, the extreme variability 
in cancer prognosis may alter the decision process. There are many studies evaluating 
decision making in congestive heart failure patients but this differs from AS as 
interventions are medicinal rather than procedural.  
            As TAVI becomes increasingly accessible and indication for its use expands, it is 
important that nursing researchers recognize the gap that exists and extend research to 
understand and include the personal choices of patients with aortic stenosis. Patient-
centered medicine indicates that health care providers direct their attention to the illness, 
not the disease. Guiding patient-centered decisions about making health care decisions 
should include evidence-based medicine with patient-centered medicine, incorporating 
the patients’ values, goals, and preferences.  
Purpose of the study  
            There is a gap in research about what is important to people with aortic stenosis 
when making health care decisions. Qualitative research will help address the gap to 
encompass the patient’s perspective as domains that are important to their health 
decisions. By utilizing the richness and depth of qualitative research, the aim of this study 
is to illuminate the subjective meaning of the complex phenomenon of the lived 
experience of the person with AS and his or her decision not to seek medical intervention.  
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Two main research questions will be addressed: 
1) What is it like living with AS?  
2) Why did you choose not to have the TAVI procedure?  
Obtaining a richer understanding of the complexity of people’s choices for 
treatment options, health care providers can support older adults’ decision-making with 
dignity and autonomy. Incorporating the knowledge learned from this study, nurse 




















In this exploratory qualitative study, the researcher used a phenomenological 
approach utilizing interviews conducted with elderly people living with aortic stenosis. 
Using the richness and depth of qualitative research permitted fuller understanding of the 
complex phenomenon of what leads to a person’s decision not to seek medical 
intervention as experienced by the patient. A convenience sample of participants from a 
medical and teaching hospital in the northeast was obtained. To capture the rich account 
of each participant’s expert knowledge and experience of living with aortic stenosis, open 
ended questions during the interview included 1) What is it like living with AS? 2) You 
decided not to have a TAVI procedure, tell me about that decision. This open-ended style 
encouraged the participants to take the lead in telling their stories. If the answers were 
limited, participants were encouraged to elaborate on their shared descriptions.  
Sample  
A list was obtained from the cardiology team at a medical and teaching hospital in 
the northeast of people with severe, symptomatic aortic valve stenosis who were not 
surgical candidates for an aortic valve replacement and declined to have the transcatheter 
aortic valve implantation. The time frame for the study commenced January 2013 
through January 2015. A convenience sample from the list included those who agreed to 
participate in the research. We anticipated approximately six individuals would take part 
in this study. 
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Following approval by the University of Vermont and the Hospital’s Institutional 
Review Board, the researcher contacted the TAVI cardiology team by email. An 
overview of the thesis on TAVI was provided as well as explanation of the thesis as part 
of the graduate requirement for the Master of Science Degree as an Adult Nurse 
Practitioner. The researcher requested the name and contact number of participants who 
elected not to have the TAVI from the hospitals TAVI database. The database is inclusive 
of all patients referred to the TAVI team for the procedure since the hospital obtained 
approval to perform TAVI’s in 2012. From this database, the researcher obtained the 
names of participants who declined to have the TAVI from January 2013 to January 
2015. Once the sample was obtained, the Adult Nurse Practitioner on the TAVI team 
mailed an Introduction Letter (appendix A), a Research Informational Sheet (appendix 
B), and a Consent Form Update (appendix C) introducing the researcher, an overview of 
her thesis proposal, and informed the participants to call her for questions or to decline 
participation in the study. From those who did not decline to be part of the study, the 
researcher followed up with a telephone call in 7-10 days from the date the letter was 
mailed, and if the participant was interested, offered to schedule a meeting in the person’s 
home or conduct the interview by telephone.  
Data Collection  
Consent was inferred if the participant agreed to participate in the study following 
review of the Research Informational Sheet. The interview was conducted by telephone, 
and audiotaped to obtain a true account using the participant’s own words. At the 
beginning of the interview each participant was offered the opportunity to ask questions 
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and was reassured of their anonymity and the confidentiality of data obtained. No real 
names were used. Participants and records were coded with a confidential name for the 
purpose of maintaining confidentiality. Records were kept in a locked file at the 
researcher’s home and on a secured computer network and were accessible with a 
password only known by the researcher.  
Maintaining effort to follow the principles of phenomenological inquiry and 
ethical inquiry, interviews were flexible and responsive to context to encourage 
participants to speak freely.  
Field notes were recorded within one hour of interview completion including tone 
of voice, eagerness or reluctance to engage, supportive family members present, and 
reflections and interpretations.  
Data Analysis 
According to Barnett (2005) data analysis in phenomenological research begins 
during data collection with active listening, reflection, clarification and intuiting. Using 
the philosopher Martin Heidegger’s interpretive phenomenological methodology, the 
researcher explored themes of why some people choose not to have the TAVI procedure. 
According to Heidegger, the ontological view on the nature of being and meaning of the 
lived experience has a larger meaning in being and more breadth than what we can see 
(Dowling & Cooney, 2012). Following Heideggerian hermeneutic research, the data 
obtained provided the researcher an understanding of what it is like to live with aortic 
stenosis as described by participants, and upon data analysis, comments were gathered 
that evolved during the interviews. Audio recordings of the interview were transcribed 
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verbatim using Dragon Dictate software program. Transcripts were read and reread. 
Information was classified, indexed, and categorized into similar concepts. It is important 
to note that this was not a linear process, but a continuous review and iterative process. 
To provide a good level of rigor to fortify trustworthiness, a method of analysis 
was included: a transcriptionist was hired and contents reviewed by the researcher twice, 
reading all transcriptions for an overall understanding, writing interpretive summaries, 
analyzing transcriptions as a group to identify themes, and comparing and contrasting 
texts to identify, describe and interpret consistent meanings. Auditability was maintained 
with organization of two audio recordings, transcripts, field notes, and codes. The audit 
trail established trustworthiness and confirmability. The author provided rich contextual 
narrative to preserve the uniqueness of each participant’s lived experience and allow 
understanding of the phenomenon investigated.  
The researcher holds no presumptions that this study represents all people who 
make the decision on the TAVI intervention, rather offer insight to understand why some 
choose not to have a procedure that is purported to expand their longevity and improve 










            There were 75 potential subjects during the time frame of January 2013 to 
January 2015. From the 75 initial subjects 19 have deceased, 16 had the SAVR, 5 had the 
TAVI, 16 didn’t meet criteria due to multi-factorial reasons, failed memory, alcohol 
abuse, non compliance, and 13 were excluded for various reasons. The remaining eight 
people who met the study criteria were sent letters. Of the eight participants one had 
deceased, one declined, two did not return a call following three telephone calls with 
messages left, leaving four participants who agreed to be interviewed. The four 
participant’s age range was 82 to 89 years old (Mean = 84.5). Two participants were 
female and two were male. The names were changed to protect the identity of these 
participants. The duration of the interviews were between six minutes and thirty-four 
minutes. Participants varied in willingness to elaborate on discussions, some were 
reluctant to expand on responses while others were more willing to share details. 
           Themes identified during telephone interviews included independence, fear of 
unknown prognosis and sources of support. The data are presented through the use of 
quotes of the participants on questions asked, what is it like to live with aortic stenosis 
and what factored into your decision not to undergo a TAVI. 
Independence 
            Three of the four participants remarked on shortness of breath and their individual 
functional ability. Perception and evaluation of symptoms entails multiple factors that 
characterize the symptom experience. The natural progressive disease process in patients 




I don’t feel bad. I’m not really short of breath, only when I exert myself, but that 
could be my age. (Mrs. Sachs) 
 
Well, right now I feel fine. I mean, I felt good for quite a long time so I never 
went back to see (the doctor). Well, I get tired, but I don’t get out of breath or 
anything. (Mrs. Bernard) 
 
I don’t know I have it (AS) until I go to the doctors and they remind me. My  
breathing is no worse than it’s been for years. (Mr. Spark)  
 
            As the disease progresses, quality of life and one’s ability to maintain daily and 
social activities is a significant factor influencing the participant to pursue treatment 
options. The functional limitations the participants mentioned were due to their 
comorbidities rather than aortic stenosis symptoms.  
 
I have a very active lifestyle, I go to physical therapy three times a week…I have  
doctor’s appointments, and I go out to lunch some times. My hip needs replacing 
but I go to physical therapy, that’s the only thing that bothers me. (Mrs. Sachs) 
 
I can do my work and I can go shopping, I can do things like that. No heavy stuff. 
No it’s not so bad (arthritis), that’s what I can’t understand. It isn’t as bad as it 
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was when I was younger, and you would think it would be, now that I’m older 
that it would be worse. It isn’t. (Mrs. Bernard) 
 
I am too active right now. I volunteer at the hospital two days a week and two 
days a week at residence. I go to bingo every Monday and Tuesday. I love Church  
       Street on weekends and other days in good weather.  I’m walker dependent, rehab   
       would be difficult. (Mr. Spark)  
 
            Three of the four participants expressed living in their home as important. Values 
differ between individuals as degrees of importance vary with tradeoffs that may occur 
with their decision.  
 
I want to stay in my home as long as I can. (Mrs. Sachs) 
 
Well she (the doctor) said that after all of that I might eventually have to end up in 
a nursing home, and that did it [emphasis added]. I have my own home and I’d 
like to stay in it as long as I can. (Mrs. Bernard) 
 







Fear of the unknown 
All participants in this study noted living with AS presently was favorable over 
the possibility of post procedure morbidity and mortality and family as a source of 
support and comfort. Living with known disabilities was acceptable, whereas the 
potential risk for stroke, dialysis or death was a strong influence in determining not to 
have the TAVI procedure. 
 
They said I would be on dialysis if I had this. I don’t want to live dependent on a 
machine, that’s no way to live. (Mrs. Sachs) 
 
If I had to sit in a chair all day or lay in bed all of the time I wouldn’t like that 
either, I want to be able to do something. Well, I can’t live like I used to, I mean, I 
can do the best I can. (Mrs. Bernard) 
 
First they give you a pamphlet over there [at the cardiologist’s office] and it tells 
you that it may cause you to have a stroke or to die.  I think there’s something 
like, I don’t know, a 30% chance of dying and a 10% chance of having a stroke.  
That was written in a pamphlet, so that’s why I decided not to have it.  I don’t 
want to have a stroke or be paralyzed or have someone take care of me. (Mr. 
Landry) 
 
            I don’t want to have a stroke and be in bed forever. (Mr. Spark)  
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            Prognosis is a variable inherent to any procedure.  For a person to make an 
informed decision to have the TAVI procedure, information provided by the provider 
included disclosure of relevant risks, benefits, and uncertainties related to treatment 
options. A remark not to pursue the TAVI as reported by Mrs. Sachs, “The doctor 
couldn’t give me any guarantees.”  Mrs. Bernard noted, “I decided that I didn’t think I 
wanted to do it because after all that stuff (pre procedural workup) that the procedure 
might not work. I just can’t see going through all that stuff then it probably wouldn’t do 
anything anyway.”  
Source of support 
            Family is frequently a source of support and comfort. Three of the participants 
live with someone; a daughter, son or wife and one lives independently, and one has a 
daughter he sees multiple times per week. In this study, two participants mentioned 
family contributes to their being able to live at home and two noted the family provides 
socialization. One participant found support in a deity.  
 
I go out to lunch with my daughter sometimes and she comes around a lot. (Mrs. 
Sachs) 
 
I have a son that lives with me so he helps me out with things I shouldn’t do. He 
      lives with me, he helps me out a lot.  I don’t drive or anything like that so when I  
       need to go shopping or need to go someplace he takes me.  So that works out  
 good.  (Mrs. Bernard) 
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My wife and I get around. She can help me with the things I can’t do. (Mr. 
Landry) 
 
I live alone but one daughter lives in the area and I see her a few times a week. 
(Mr. Spark)  
 
I’m 85. I’ve lived a good life. I guess I leave it in God’s hands when it’s my time 
to go. (Mrs. Sachs) 
            





























Comparison to what is known/principal findings 
 
            While the numbers of elderly people with chronic illness increase, how they 
choose what medical options they make is changing. Patient-centered care, a renewed 
concept, is beneficial for envisioning a new approach to advanced care planning. 
Patients’ attitudes about using their own aims and values to make decisions should be 
included in their treatment options. Patient-centered care is defined as a partnership 
among patients, families and health care providers to design patient specific education 
and support to assist in making decisions that are respectful of the patient’s needs and 
wishes (IOM, 2013).  
            The data from this study provided comments on what it is like living with AS 
from the patients’ perspective. Three of the four participants reported shortness of breath 
symptoms as minor, having minimal effect on their daily life. This finding challenges 
other studies noting that dyspnea on exertion is the most common symptom of AS (Go et 
al., 2014; Bach, 2011; Horrocks, 2014).  
            All but one participant expressed their limited functional ability was due to 
comorbidities rather than the effects of aortic stenosis but their overall QoL was 
relatively good. The importance of quality of life is well recognized, but there is no single 
agreement of the definition of QoL. Ferrans, Zerwic, Wilbur & Larson (2005) argued that 
quality of life includes health status, physical functioning, symptoms, psychosocial 
influences, well-being, life satisfaction, and happiness variables yet the multiple variables 
hinder comparison of research conclusions and makes application to practice difficult.  
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According to Sousa & Oi-Man (2006) QoL is a multidimensional construct with multiple 
variables albeit without supposition about the associations between them. Milton (2013) 
reports QoL tools offer information on functional abilities but include little about the 
lived human experience. McRae & Rodger (2012) posit that nursing research is needed to 
improved utilizing health related QoL in the AS population.  
            Treatment choices for AS include SAVR, TAVI, or medical management, with or 
without a balloon aortic valvuloplasty.  But some patients choose not to have the TAVI. 
This study aimed to identify themes about the decision to decline to have the TAVI by 
participants with AS. Making informed decisions about treatment options in patients with 
aortic stenosis should include comprehensive information with benefits and risks 
regarding surgical, procedural or medical management. But it is unclear how much 
influence is attributed to patients’ preferences versus what is proposed to them by their 
provider or how much of their own beliefs and values are included in the decision making 
process. Shim, Russ, & Kuafman (2006) state that information proposing cardiac 
intervention by providers as routine with diminished procedural risks fuels the desire for 
intervention, therefore standard practice is replacing choice. The lack of clarity of how 
much is attributed to chronic illness patients’ preferences in decision making is further 
supported by Winterbottom, Bekker, Conner, & Mooney (2012).  
            An expectation of the ANA’s Code of Ethics for Nurses with Interpretive 
Statements (2014) is respect for human dignity, which includes self-determination of 
treatment options, including the choice of no treatment. Ethical responsibility 
incorporates informing patients of their health condition and treatment options, including 
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realistic prognosis, according to Radley & Payne (2009). Nurses have an ethical 
responsibility to insure a more proactive approach to enable patients to fully engage in 
discussion regarding AS treatment options.  
             There has been limited research published addressing collaborative decision 
making with patients with aortic stenosis. Similar themes found in this study, such as 
independence, fear of unknown prognosis and sources of support, are themes identified in 
CHF, cancer, and dialysis research. But there is little relationship between persons with 
these diseases and elderly people living with AS who choose non-procedural treatment 
options.   
             A variety of factors influenced the choice of these participants not to have the 
TAVI. Potential morbidity consequences, the risk of stoke or dialysis, were too heavy a 
burden for some to proceed with a TAVI.  A determinant for two people was unknown 
prognosis. They would rather accept what lifestyle they presently live than to face an 
unknown health condition. The fear of loss of independent living, specifically in their 
own home, gave resolve to not proceed with the TAVI and defined living independently 
as the only option they wanted to live.  
            Sources of support by family offered companionship or a means to remain in their 
home. One person commented on “God” as a partial determination of her life expectancy. 
In other research with end-of-life cohorts, awareness of culture and religious differences 
can facilitate understanding in patient choices when discussing treatment options. 
Although this may influence elements in decision-making, clinicians should not make 
assumptions about religious or cultural expectations in a palliative approach. 
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Implications for advanced practice/clinical implications 
 
 According to the American Academy of Nurse Practitioners (AANP), assessment 
and diagnosis by the Advanced Practice Nurse (APN) is a standard of care for managing 
patients. The ANP roles are to provide direct expert clinical practice, guidance and 
coaching to patients, families, and other care providers, consultation, research, clinical, 
professional, system leadership, collaboration and ethical decision-making. This is the 
first known study designed to improve the understanding of what it is like living with 
aortic stenosis as perceived by the participant and to improve understanding of factors 
that aid in the participant’s decision not to have the TAVI.  Focusing on client-centered 
care is closely aligned with core nursing values. The research findings are important in 
helping health care providers offer treatment options for symptomatic aortic stenosis 
patients and optimize holistic decision making with patients incorporating the patients’ 
values and goals.  
Nursing research, like nursing itself, concerns many different and complex 
phenomena. By incorporating our knowledge from our learned disciplines, such as 
biology, philosophy, psychology, with our experience and caring we acknowledge the art 
of nursing. Florence Nightingale work and writings reflect the concept and philosophy 
for holistic nursing. Nightingale’s legacy is a blueprint practice of observation, inquiry, 
experience, and nursing art according to Jean Watson (2010). 
            The data gained from this study provided a deeper insight into the complexity of 
living life with a long-term illness. Having a richer understanding of the complexity of 
people making choices for treatment options, advanced practice nurses can provide 
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guidance to patients and families with ethical decision-making, providing holistic health 
care that maintains dignity and autonomy. The ANA’s Code of Ethics (2014) states the 
right to autonomy, whereby individuals determine their own treatment choices, is an 
accepted ethical and legal foundation of healthcare. In the midst of this great change to 
provide patient-centered care, the nurse practitioners are leaders of the evolving clinical, 
professional and health care system. Incorporating the knowledge gained from this study, 
advanced nurse practitioners can improve in their role as patient educators and advocates 
and optimize collaboration with other health care professionals.  
             The information gathered in this study will help advance quality and relevance of 
practice in providing health care decisions tailored to people with aortic stenosis. 
Incorporating the patient in research is addressed in multiple venues. In a recent 
legislative change, The Patient Protection and Affordable Care Act of 2010 created the 
Patient-Centered Outcomes Research Institute (PCOPI). The PCOPI recognizes data 
obtained from qualitative interviews of elicited responses of the patients’ experiences’ 
with their conditions and/or treatments promotes value of the patients’ voice into the 
research process (Fleurence et al., 2014). As mentioned by Selby, Beal, & Frank (2012), 
engaging the patient in clinical effectiveness research emphasizes the importance of 
patient-centered perspectives when conducting research.  
            This study identified that some people choose not to pursue procedural or surgical 
technology when given treatment options for AS. Yet, the trajectory of AS prognosis by 
medical therapy alone is limited. To provide expert clinical care and honoring the 
patient’s choice of medical modality for treatment, the integration of a palliative 
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approach in nursing practice is essential to support patients and provide best practice for 
patients with AS in their last years of life. A new clinical trial being developed, Future 
Care Planning, is being proposed for patients with advanced heart disease by Denver et 
al.,  (2014). It recognizes concerns in providing high quality holistic care by initiating 
discussion of palliative care. Lauck et al. (2014) introduced a palliative approach to care, 
focusing on meeting the patient’s physical, psychosocial and spiritual needs in life 
limiting illness such as the AS and TAVI population. Nurse practitioners can provide 
system leadership by the development and integration of the palliative care team with the 
University of Vermont Medical Center’s TAVI team, to aid clinicians in offering 
continuity of care when TAVI is not an option.  
Limitations 
             This pilot study provided the PI with an opportunity to share and reflect on 
patients’ experiences and interpretations. There were limitations incurred, namely sample 
size, style of interview, and length of interviews. 
            Sample recruitment in obtaining people for this study was challenging. 
Recruitment was difficult due to the limited number of people in the rural area, the 
limited number of people who choose not to have the TAVI, and attrition due to the 
limited longevity of life in this population. This is a very specific population, which 
narrows the amount of people for sample selection. Hence, a pilot study was adopted, as 
there were a limited number of patients with symptomatic AS who were not surgical 
candidates and choose not to have the TAVI procedure. Attrition was also a significant 
factor as elderly people with AS are a vulnerable cohort. Of the original 75 people, 
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twenty-five percent have deceased. Cooley et al. (2003) study identified refusal to 
participate was due to health limitation, lack of interest, and inconvenience and attrition 
due to death and severity of illness. Fisher et al. addressed the difficulty in recruitment of 
people when conducting research with end-of-life populations in their study (2012). 
Recruitment might be more successful if patients were informed of the study during their 
workup when the relevance of the study is most obvious (Fisher et al., 2012; Sharp, 
2010). The introduction of this study by the TAVI team at the time of consultation might 
possibly have provided more effective recruitment.   
            Another limitation was the style of interviews. The original study design was to 
be done using personal interviews in the participants’ homes.  As the four participants 
were reluctant to have the PI into their home, the alternative interview occurred using the 
telephone. This method limited researcher observation with personal contact of the 
participants’ gestures, expressions, and environmental setting.  
            Lastly, the length of interviews was short. Researchers must consider the varying 
characteristics and challenges inherent in this cohort prior to initiating further study. 
According to Fisher et al., (2012) understanding the dynamics and variances among 
cohorts is key to conducting research.  
            A distinguishing feature of pilot studies is that the number of participants may be 
small but they provide rich experiences of unique situations. It is important to realize the 
quality of responses from each participant, as it is the individual patients’ value on their 
decision-making process. Epistemology includes the view that the truth varies and is 
subjective. Using a pilot study according to Stanly (2010) offers the opportunity for the 
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researcher to test the research question, assess the relevance and suitability of the test, 
and gather preliminary data for future research. Although this study was small, inclusive 
of only four participants, the strength of the study comes from gathering evidence from 
the participants directly. While the participants provided rich information for the 
purposes of this study, there is insufficient material to derive themes regarding 
generalizability of the findings.  
            Historically, qualitative research can be dismissed as results and findings obtained 
can lack validity and reliability. Although using a qualitative discipline, dealing with the 
complexity of personal reported symptoms, yields ideas that emerge in a wider social 
context.  
Discussion of future research/study to pursue 
 
             Research related to what it is like living with AS and reasons not to pursue the 
TAVI with patients who have aortic stenosis has numerous potential benefits for people, 
such as sharing their stories, reflecting on their experiences and choices, and contributing 
to research. This pilot study has generated important new information and points to the 
need for further research with larger scale studies to explore issues raised in a wider 
population. Further research is needed in patients with long-term illness and decision-
making. Addressed in this section is utilization of different research methods, increasing 
the geographic area and length of time of study, and expanding on knowledge obtained 
from this study to gain a broader understanding of what is involved in decision-making in 
this cohort. 
            The small sample size potentially omits other perspectives that may be important, 
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so future research might use a cross sectional design to increase the number of  
participants.  Future study could include three or four adjoining states to Vermont over a 
period of two to three years. Using a cross sectional method with expansion of the 
geographic area and lengthening the duration of study, might improve the number of 
participants and enhance diversity, as Vermont is a small rural area.  
            Although this study had limited participants, the participants marginalized 
symptoms of shortness of breath and qualified QoL as relatively good. Further research 
might be a comparison of people who choose not to have a TAVI who described their 
symptoms of shortness of breath as insignificant to people with AS who pursued 
interventions as shortness of breath is the primary contributing issue that patients seek 
treatment recognized in literature. Is this acceptance or adaptation?  Another research 
study with this cohort could be to review the participant’s QoL life assessment measures 
and note if the participants in this study had a higher QoL score than others who choose 
to have the TAVI. Having supported data would enhance the qualitative findings. 
            This pilot study has identified important concepts for shared decision making of 
treatment options for future research with larger-scale studies within this population that 
may be transferable to a wider population.  
Conclusion 
             Since the initial TAVI procedure in 2011, there have not been any published 
studies on individuals’ decisions not to pursue having the TAVI procedure. Most studies 
reported an improvement of quality of life using quantitative measures, but do not focus 
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on the individuals’ ethos on end-of-life options. The patients’ perspective and role in this 
process remain largely unexplored.  
            Hopefully the information gathered in this study will help advance quality and 
relevance when providing health care decisions tailored to people with aortic stenosis 
who choose medical treatment. The study hopes to aid clinicians design interventions 
aimed at continuity of care when TAVI is not an option. The findings in this study may 
be important in helping to provide a better understanding of the influences on the 
decision making process, the need for further research in the area for patients deciding 
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Hello Mr./Mrs./Ms. __________, 
 
 
I am Barbara Worgan, the Nurse Practitioner working with Dr. Dauerman on the 
Transcatheter Aortic Valve Implantation (TAVI) team at Fletcher Allen Heath Care. You 
met with Dr. Dauerman on (date) to discuss the possibility of having the TAVI and 
decided that you did not want to have the procedure at that time. 
 
I am wondering if you would be interested in taking part in a research study on living 
with Aortic Stenosis being done by a Graduate Nurse student at the University of 
Vermont. Her name is Gayle Hagen-Peter. She has been a nurse for thirty-two years and 
has returned to school to obtain a Masters of Science Degree as an Adult Nurse 
Practitioner. This research is an opportunity to help practitioners understand what it is 
like living with Aortic Stenosis and what factors was part of your decision not to have the 
TAVI. 
  
If you are NOT interested in being part of this research process, you may contact me, 
Barbara Worgan, at 802-847-4600. Otherwise, Gayle Hagen-Peter, the Principal 
Investigator of this research, will contact you by telephone in 7-10 days to see if you 
would like to learn more and/or participate in this research study. I also am including a 
research information letter that provides more detail.  
 
If you have any questions about this study, you may contact me, Gayle Hagen-Peter at 
802-847-5589 or at 802-578-9809. 
 
Thank you for your consideration in participating in this exciting research, 
 
 


















Research Informational Sheet 
 
Title Of Research Project:  Living with Aortic Stenosis: a phenomenological study of                                                                     
                                   patients’ experiences and subsequent health choices 
 
You are being invited to take part in this research study because you have aortic stenosis 
and decided not to have the Transcatheter Aortic Valve Implantation (TAVI) with 
Fletcher Allen’s Health Care TAVI team. Please ask any questions you may have before 
agreeing to be in the study.  
 
Why Is This Research Study Being Conducted? The purpose of this study is to gain 
insight into the experience of the person who lives with aortic stenosis and what factors 
into the person’s decision not to have medical intervention. 
  
How Many People Will Take Part In The Study? We anticipate approximately 6 
individuals will take part in this study. 
 
What Is Involved In The Study? You are being asked to take part in an interview lasting 
one hour at your home or another convenient location. The questions included will be: 
What is it like living with Aortic Stenosis and tell me about your decision not to have the 
TAVI procedure. The interview will be audio recorded for transcription purposes only. 
Limited private medical information regarding your study eligibility will be added to 
your research record.  
 
What Are The Discomforts or Risks Of The Study? Although potential risks of this study 
are minimal, the conversation in deciding not to have the TAVI procedure might cause 
you to have thoughts and feelings that make you uncomfortable as you reflect upon your 
decision. If you become distressed you can raise your hand to speak with the researcher, 
you can take a break or discontinue the interview. Fletcher Allen Health Care's Patient 
and Family Advocacy phone number is 802-847-3500 and Case Management and Social 
Work number is 802-847-3553 for community and counseling resources if you feel you 
need their services. 
There is a risk that confidential information might accidentally be disclosed. Professional 
standards for protecting confidential information will be used to minimize this risk. 
 
What Are The Benefits Of Participating In The Study? 
There may be no direct benefit to you for your participation. However, others may benefit 
in the future by improving understanding of Nurses Practitioners to help communicate 




What Other Options Are There? Your participation is voluntary and you may refuse to 
participate or withdraw at any time without penalty or prejudice. If you choose to do so, 
your information will be eliminated from the study data and no longer be accessible by 
the researcher or anyone else. 
 
Are There Any Costs? There is no cost to you other than your time. 
 
What Are The Compensation? There is no monetary or material compensation. 
 
What About Confidentiality? All information and audio recording will be kept in a 
locked file at researcher’s home. No names will be used and all data will be coded. Only 
the researcher will listen to the tapes. The tapes will be kept on a secured computer 
network and are accessible with a password only known by the researcher. 
Names of the participants will be coded and a master list to link the identity of the 
participant will be kept on a private network with passcode access known only by the 
researcher. The results of this study will be used for publication, but your confidentiality 
will be maintained. Upon request representatives of the University of Vermont 
Institutional Review Board will be granted direct access to your research record for 
verification of research procedures and/or data.  
 
Contact Information You may contact Gayle Hagen-Peter, the researcher in charge of this 
study, at 802-578-9809 for more information about this study. If you have any questions 
about your rights as a participant in a research project you should contact, Nancy 
Stalnaker, the Director of the Research Protections Office, at the University of Vermont 
at 802-650-5040. 
 
Statement of Consent You have been given a summary of this research study. Your 
participation is voluntary, and you may refuse to participate without penalty or 
discrimination. By completing the interview, you are agreeing to participate 
in this study. Your verbal permission to take part in this study will be documented in the 
research record.  
 
 
Name of Principal Investigator: Gayle Hagen-Peter 
Address: University of Vermont, Burlington, VT. O5405 
Telephone Number: 802-578-9809 
 
Name of Faculty Sponsor: Sarah Abrams, Ph.D. 
Address: University of Vermont, Burlington, VT. O5405 








The University of Vermont  
Committees on Human Research  
Serving the University of Vermont and 
The University of Vermont Medical Center Inc.  
 
 
Consent Form Update 
Effective Wednesday, November 12, 2014, our affiliated hospital, Fletcher Allen Health 
Care, Inc., officially became “The University of Vermont Medical Center Inc.” In 
consent forms, please substitute all references to Fletcher Allen Health Care or FAHC 
with The University Medical Center or UVM Medical Center. This is only a change in 
their name. There are no changes to study procedures, risks or benefits. This change was 
made to more clearly reflect the academic core and their position as one of the nation’s 
most respected academic medical centers, and to proudly demonstrate their strong ties to 
the University of Vermont.  
 
RESEARCH PROTECTIONS OFFICE  
213 Waterman Building, 85 South Prospect Street, Burlington, VT 05405 
(802) 656-5040, http://www.uvm.edu/rpo/ Equal Opportunity/Affirmative Action 
Employer  
 
 
